“treatment resistant depression”的搜索结果，显示 251-260 项，共有 7736 项
Targeted therapy may be combined with chemotherapy or other treatments. It may be an option for relapsed or refractory anaplastic large cell lymphoma. Targeted ...
A Study To Evaluate APG2575 Combined With Novel Therapeutic Regimens To Treat Subjects With Relapsed Or Refractory ... treatment-related side effects, and improve ...
... therapy of TILT-123 and pembrolizumab in patients with platinum resistant or refractory ovarian cancer. A Study Of Intratumoral Injection Of Autologous ...
... treatment, post-treatment and (when available) ... Late effects of therapy including targeted ... resistance to 131I-MIBG and crizotinib. The ...
This clinical trial evaluates the safety and feasibility of tumor treating fields (TTF) in the treatment of spinal leptomeningeal disease in patients with ...
The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's transformation, and ...
... therapy of TILT-123 and pembrolizumab in patients with platinum resistant or refractory ovarian cancer. Testing The Addition Of MEDI4736 (Durvalumab) To ...
... therapy, but this study will administer treatment in approximately 3 weeks. ... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase ...
... treated with ALL therapy ... resistant chronic lymphocytic leukemia. Patients ... treatment in patients with treatment-naive ALK-positive advanced NSCLC.
PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer.
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。